Kaplan-Meier analysis indicated that ESCC patients with higher expression of CDKL3 and ATG5 had shorter overall survival (p = 0.011, p = 0.004, Figure 7C). This evidence concerns the gene CDKL3 and esophageal squamous cell carcinoma.